Moreover, miR-199b also functions as a tumor suppressor in medulloblastoma, hepatocellular carcinoma and breast cancers by affecting targets such as HEIS1, HIF1α or HER2 [23–25]. This evidence concerns the gene HIF1A and hepatocellular carcinoma.